Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 290

1.

Active drug safety surveillance: a tool to improve public health.

Platt R, Madre L, Reynolds R, Tilson H.

Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1175-82. doi: 10.1002/pds.1668.

PMID:
18823068
[PubMed - indexed for MEDLINE]
2.

The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safety.

Lo Re V 3rd, Strom BL.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):818-25.

PMID:
17436357
[PubMed - indexed for MEDLINE]
3.

A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.

Lindquist M, Ståhl M, Bate A, Edwards IR, Meyboom RH.

Drug Saf. 2000 Dec;23(6):533-42.

PMID:
11144660
[PubMed - indexed for MEDLINE]
4.

Risk assessment of drugs, biologics and therapeutic devices: present and future issues.

Centers for Education and Research on Therapeutics Risk Assessment Workshop.

Pharmacoepidemiol Drug Saf. 2003 Dec;12(8):653-62.

PMID:
14762981
[PubMed - indexed for MEDLINE]
5.

Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.

Moore KM, Duddy A, Braun MM, Platt R, Brown JS.

Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1137-41. doi: 10.1002/pds.1642.

PMID:
18763248
[PubMed - indexed for MEDLINE]
6.

The Erice Manifesto: for global reform of the safety of medicines in patient care.

[No authors listed]

Drug Saf. 2007;30(3):187-90.

PMID:
17343426
[PubMed - indexed for MEDLINE]
7.

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont-Salamé G, Catania MA, Salvo F, David A, Moore N, Caputi AP, Sturkenboom M, Molokhia M, Hippisley-Cox J, Acedo CD, van der Lei J, Fourrier-Reglat A; EU-ADR group.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1176-84. doi: 10.1002/pds.1836.

PMID:
19757412
[PubMed - indexed for MEDLINE]
8.

Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database.

Ståhl M, Lindquist M, Edwards IR, Brown EG.

Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):355-63.

PMID:
15170764
[PubMed - indexed for MEDLINE]
9.

Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

Almenoff JS, LaCroix KK, Yuen NA, Fram D, DuMouchel W.

Drug Saf. 2006;29(10):875-87.

PMID:
16970511
[PubMed - indexed for MEDLINE]
10.

The US drug safety system: role of the pharmaceutical industry.

Gibson BR, Suh R, Tilson H.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):110-4.

PMID:
17724741
[PubMed - indexed for MEDLINE]
11.

Database size and power to detect safety signals in pharmacovigilance.

Hammond IW, Gibbs TG, Seifert HA, Rich DS.

Expert Opin Drug Saf. 2007 Nov;6(6):713-21. Review.

PMID:
17967160
[PubMed - indexed for MEDLINE]
12.

Perspectives on the use of data mining in pharmaco-vigilance.

Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K, Walsh L, Yee C, Sacks ST, Yuen N, Patadia V, Blum M, Johnston M, Gerrits C, Seifert H, Lacroix K.

Drug Saf. 2005;28(11):981-1007. Review.

PMID:
16231953
[PubMed - indexed for MEDLINE]
13.

Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.

Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R.

Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):226-34. doi: 10.1002/pds.1706.

PMID:
19148879
[PubMed - indexed for MEDLINE]
14.

Data safety and drug safety in Germany: a closing gap?

Rathmann W.

Pharmacoepidemiol Drug Saf. 2001 Dec;10(7):625-30.

PMID:
11980251
[PubMed - indexed for MEDLINE]
15.

The role of data mining in pharmacovigilance.

Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP.

Expert Opin Drug Saf. 2005 Sep;4(5):929-48. Review.

PMID:
16111454
[PubMed - indexed for MEDLINE]
16.

Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.

Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I.

Drug Saf. 2007;30(8):715-26. Erratum in: Drug Saf. 2008;31(2):183.

PMID:
17696584
[PubMed - indexed for MEDLINE]
17.

Safety related drug-labelling changes: findings from two data mining algorithms.

Hauben M, Reich L.

Drug Saf. 2004;27(10):735-44. Erratum in: Drug Saf. 2006;29(12):1192.

PMID:
15350157
[PubMed - indexed for MEDLINE]
18.

Improving communication of drug risks to prevent patient injury: proceedings of a workshop.

Campbell WH, Califf RM.

Pharmacoepidemiol Drug Saf. 2003 Apr-May;12(3):183-94.

PMID:
12733471
[PubMed - indexed for MEDLINE]
19.

Pharmacoepidemiology.

Evans SJ.

Br J Clin Pharmacol. 2012 Jun;73(6):973-8. doi: 10.1111/j.1365-2125.2012.04248.x.

PMID:
22360737
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.

Meijer WM, Cornel MC, Dolk H, de Walle HE, Armstrong NC, de Jong-van den Berg LT; EUROCAT Working Group.

Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):675-82.

PMID:
16761260
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk